Article info

Download PDFPDF

Administration of benralizumab in a patient with severe asthma admitted to the intensive care unit with COVID-19 pneumonia: case report

Authors

  • Johannes Anthon Kroes Department of Clinical Pharmacy and Pharmacology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands PubMed articlesGoogle scholar articles
  • Sander Wilhelm Zielhuis Department of Clinical Pharmacy and Pharmacology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands PubMed articlesGoogle scholar articles
  • Carina Bethlehem Department of Intensive Care, Medical Centre Leeuwarden, Leeuwarden, The Netherlands PubMed articlesGoogle scholar articles
  • Anneke Ten Brinke Department of Pulmonary Diseases, Medical Centre Leeuwarden, Leeuwarden, The Netherlands PubMed articlesGoogle scholar articles
  • Eric Nico Van Roon Department of Clinical Pharmacy and Pharmacology, Medical Centre Leeuwarden, Leeuwarden, The NetherlandsGroningen Research Institute of Pharmacy, Unit of Pharmacotherapy, Epidemiology and Economics, Department of Pharmacy, Rijksuniversiteit Groningen Faculty of Science and Engineering, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Johannes Anthon Kroes, Department of Clinical Pharmacy and Pharmacology, Medical Centre Leeuwarden, Leeuwarden 8934AD, The Netherlands; j.a.kroes{at}rug.nl
View Full Text

Citation

Kroes JA, Zielhuis SW, Bethlehem C, et al
Administration of benralizumab in a patient with severe asthma admitted to the intensive care unit with COVID-19 pneumonia: case report

Publication history

  • Received December 16, 2020
  • Accepted February 15, 2021
  • First published April 21, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.